Article ID Journal Published Year Pages File Type
1971524 Clinical Biochemistry 2007 8 Pages PDF
Abstract
Greater recognition of ROS-modified chromatin with the autoantibodies in cancer sera is indicative of reactive-oxygen-species-induced chromatin damage in cancer patients.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Preview
Characterization of chromatin modified with reactive oxygen species: Recognition by autoantibodies in cancer
Authors
, ,